BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li F, Li H, Luo R, Pei JB, Yu XY. Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation. World J Clin Cases 2023; 11(26): 6066-6072 [PMID: 37731575 DOI: 10.12998/wjcc.v11.i26.6066]
URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6066.htm
Number Citing Articles
1
Christos Kourek, Alexandros Briasoulis, Grigorios Giamouzis, John Skoularigis, Andrew Xanthopoulos. Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failureWorld Journal of Clinical Cases 2023; 11(36): 8603-8605 doi: 10.12998/wjcc.v11.i36.8603
2
启俊 刘. Application Progress of Recombinant Human Brain Natriuretic Peptide in Clinical PracticeAdvances in Clinical Medicine 2024; 14(04): 2573 doi: 10.12677/acm.2024.1441330
3
Dahuan Shi, Xin Li, Lantao Yang, Chunmei Luo, Jing Ma. Benefits of recombinant human brain natriuretic peptide to improve ventricular function and hemodynamics in patients with ST-elevation myocardial infarction.Investigación Clínica 2024; 65(3): 335 doi: 10.54817/IC.v65n3a06